reglab/housing_qa huggingface dataset:
WA Rev Code § 69.77.040 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.77 - Investigational Drugs, Biological Products, and Devices.|69.77.040 - Patient eligibility for access and treatment with investigational product.

RCW 69.77.040 Patient eligibility for access and treatment with investigational product.A patient is eligible to request access to and be treated with an investigational product if:(1) The patient is eighteen years of age or older;(2) The patient is a resident of this state;(3) The patient's treating physician attests to the fact that the patient has a serious or immediately life-threatening disease or condition;(4) The patient acknowledges having been informed by the treating physician of all other treatment options currently approved by the United States food and drug administration;(5) The patient's treating physician recommends that the patient be treated with an investigational product;(6) The patient is unable to participate in a clinical trial for the investigational product because the patient's physician has contacted one or more clinical trials or researchers in the physician's practice area and has determined, using the physician's professional judgment, that there are no clinical trials reasonably available for the patient to participate in, that the patient would not qualify for a clinical trial, or that delay in waiting to join a clinical trial would risk further harm to the patient; and(7) In accordance with RCW 69.77.050, the patient has provided written informed consent for the use of the investigational product, or, if the patient lacks the capacity to consent, the patient's legally authorized representative has provided written informed consent on behalf of the patient.[ 2017 c 212 § 4.]
WA Rev Code § 69.77.050 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.77 - Investigational Drugs, Biological Products, and Devices.|69.77.050 - Informed consent.

RCW 69.77.050 Informed consent.(1) Prior to treatment of the eligible patient with an investigational product, the treating physician shall obtain written informed consent, consistent with the requirements of RCW 7.70.060(1), and signed by the eligible patient or, if the patient lacks the capacity to consent, his or her legally authorized representative.(2) Information provided in order to obtain the informed consent must, to the extent possible, include the following:(a) That the patient has been diagnosed with a serious or immediately life-threatening disease or condition and explains the currently approved products and treatments for the disease or condition from which the eligible patient suffers;(b) That all currently approved and conventionally recognized treatments are unlikely to prolong the eligible patient's life;(c) Clear identification of the investigational product that the eligible patient seeks to use;(d) The potentially best and worst outcomes of using the investigational product and a realistic description of the most likely outcome. This description must include the possibility that new, unanticipated, different, or worse symptoms may result and that death could be hastened by the proposed treatment. The description must be based on the physician's knowledge of the proposed treatment in conjunction with an awareness of the eligible patient's condition;(e) That the eligible patient's health benefit plan is not obligated to pay for the investigational product or any harm caused to the eligible patient by the investigational product, unless otherwise specifically required to do so by law or contract, and that in order to receive the investigational product the patient may be required to pay the costs of administering the investigational product; and(f) That the eligible patient is liable for all expenses consequent to the use of the investigational product, except as otherwise provided in the eligible patient's health benefit plan or a contract between the eligible patient and the manufacturer of the investigational product.(3) The document must be signed and dated by the eligible patient's treating physician and witnessed in writing by at least one adult.[ 2017 c 212 § 5.]
WA Rev Code § 69.77.060 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.77 - Investigational Drugs, Biological Products, and Devices.|69.77.060 - Issuer may provide coverage for cost or administration of investigational product—Denial of coverage.

RCW 69.77.060 Issuer may provide coverage for cost or administration of investigational product—Denial of coverage.(1) An issuer may, but is not required to, provide coverage for the cost or the administration of an investigational product provided to an eligible patient pursuant to this chapter.(2)(a) An issuer may deny coverage to an eligible patient who is treated with an investigational product for harm to the eligible patient caused by the investigational product and is not required to cover the costs associated with receiving the investigational product or the costs demonstrated to be associated with an adverse effect that is a result of receiving the investigational product.(b) Except as stated in (a) of this subsection, an issuer may not deny coverage to an eligible patient for: (i) The eligible patient's serious or immediately life-threatening disease or condition; (ii) benefits that accrued before the day on which the eligible patient was treated with an investigational product; or (iii) palliative or hospice care for an eligible patient who was previously treated with an investigational product but who is no longer being treated with an investigational product.[ 2017 c 212 § 6.]
WA Rev Code § 69.77.070 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.77 - Investigational Drugs, Biological Products, and Devices.|69.77.070 - Hospitals and health care facilities.

RCW 69.77.070 Hospitals and health care facilities.A hospital or health care facility:(1) May, but is not required to, allow a health care practitioner who is privileged to practice or who is employed at the hospital or health care facility to treat, administer, or provide an investigational product to an eligible patient under this chapter;(2) May establish a policy regarding treating, administering, or providing investigational products under this chapter; and(3) Is not obligated to pay for the investigational product or any harm caused to the eligible patient by the product, or any care that is necessary as a result of the use of the investigational product, including under chapter 70.170 RCW.[ 2017 c 212 § 7.]
WA Rev Code § 69.77.080 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.77 - Investigational Drugs, Biological Products, and Devices.|69.77.080 - Private right of action—Unprofessional conduct—Immunity from civil or criminal liability.

RCW 69.77.080 Private right of action—Unprofessional conduct—Immunity from civil or criminal liability.(1) Chapter 212, Laws of 2017 does not create a private right of action.(2) A health care practitioner does not commit unprofessional conduct under RCW 18.130.180 and does not violate the applicable standard of care by:(a) Obtaining an investigational product pursuant to this chapter;(b) Refusing to recommend, request, prescribe, or otherwise provide an investigational product pursuant to this chapter;(c) Administering an investigational product to an eligible patient pursuant to this chapter; or(d) Treating an eligible patient with an investigational product pursuant to this chapter.(3) The following persons and entities are immune from civil or criminal liability and administrative actions arising out of treatment of an eligible patient with an investigational product, other than acts or omissions constituting gross negligence or willful or wanton misconduct:(a) A health care practitioner who recommends or requests an investigational product for an eligible patient in compliance with this chapter;(b) A health care practitioner who refuses to recommend or request an investigational product for a patient seeking access to an investigational product;(c) A manufacturer that provides an investigational product to a health care practitioner in compliance with this chapter;(d) A hospital or health care facility where an investigational product is either administered or provided to an eligible patient in compliance with this chapter; and(e) A hospital or health care facility that does not allow a health care practitioner to provide treatment with an investigational product or enforces a policy it has adopted regarding treating, administering, or providing care with an investigational product.[ 2017 c 212 § 8.]
WA Rev Code § 69.77.090 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.77 - Investigational Drugs, Biological Products, and Devices.|69.77.090 - Pharmacy quality assurance commission may adopt rules.

RCW 69.77.090 Pharmacy quality assurance commission may adopt rules.The pharmacy quality assurance commission may adopt rules necessary to implement this chapter.[ 2017 c 212 § 9.]
WA Rev Code § 69.80.010 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.80 - Food Donation and Distribution—Liability.|69.80.010 - Purpose.

RCW 69.80.010 Purpose.The purpose of this chapter is to promote the free distribution of food to needy persons, prevent waste of food products, and provide liability protection for persons and organizations donating or distributing such food products.[ 1983 c 241 § 1.]
WA Rev Code § 69.80.020 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.80 - Food Donation and Distribution—Liability.|69.80.020 - Definitions.

RCW 69.80.020 Definitions.Unless the context clearly requires otherwise, the definitions in this section apply throughout this chapter.(1) "Distributing organization" means a charitable nonprofit organization under section 501(c) of the federal internal revenue code which distributes food free of charge and includes any nonprofit organization that distributes food free of charge to other nonprofit organizations or to the public.(2) "Donor" means a person, corporation, association, or other organization which donates food to a distributing organization. "Donor" includes, but is not limited to, farmers, processors, distributors, wholesalers, and retailers of food. "Donor" also includes persons who harvest agricultural crops or perishable foods which have been donated by the owner to a distributing organization.(3) "Food" means food products for human consumption as defined in RCW 69.04.008.[ 1983 c 241 § 2.]
WA Rev Code § 69.80.040 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.80 - Food Donation and Distribution—Liability.|69.80.040 - Information and referral service for food donation program.

RCW 69.80.040 Information and referral service for food donation program.The department of agriculture shall maintain an information and referral service for persons and organizations that have notified the department of their desire to participate in the food donation program under this chapter.[ 1983 c 241 § 4.]
WA Rev Code § 69.80.050 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.80 - Food Donation and Distribution—Liability.|69.80.050 - Inspection of donated food by state and local agencies—Variance.

RCW 69.80.050 Inspection of donated food by state and local agencies—Variance.(1) Appropriate state and local agencies are authorized to inspect donated food items for wholesomeness and may establish procedures for the handling of food items.(2) To facilitate the free distribution of food to needy persons, the local health officer, upon request from either a donor or distributing organization, may grant a variance to chapter 246-215 WAC covering physical facilities, equipment standards, and food source requirements when no known or expected health hazard would exist as a result of the action.[ 2002 c 217 § 3; 1983 c 241 § 6.]NOTES:Effective date—2002 c 217 § 3: "Section 3 of this act is necessary for the immediate preservation of the public peace, health, or safety, or support of the state government and its existing public institutions, and takes effect immediately [March 28, 2002]." [ 2002 c 217 § 4.]Finding—Purpose—2002 c 217: "The legislature finds and declares that the distribution of food by donors to charitable organizations, such as shelters, churches, and fraternal organizations, serving communal meals to needy individuals can be done safely consistent with rules and recommended health and safety guidelines. The establishment of recommended donor guidelines by the department of health can educate the public about the preparation and handling of food donated to charitable organizations for distribution to homeless and other needy people. The purpose of this act is to authorize and facilitate the donation of food to needy persons in accordance with health and safety guidelines and rules, to assure that the donated food will not place needy recipients at risk, and to encourage businesses and individuals to donate surplus food to charitable organizations serving our state's needy population." [ 2002 c 217 § 1.]
WA Rev Code § 69.80.060 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.80 - Food Donation and Distribution—Liability.|69.80.060 - Safe receipt, preparation, and handling of donated food—Rules—Educational materials.

RCW 69.80.060 Safe receipt, preparation, and handling of donated food—Rules—Educational materials.(1) No later than December 31, 2004, the state board of health shall promulgate rules for the safe receipt, preparation, and handling by distributing organizations of food accepted from donors in order to facilitate the donation of food, free of charge, and to protect the health and safety of needy people.(2) No later than December 31, 2004, the department of health, in consultation with the state board of health, shall develop educational materials for donors containing recommended health and safety guidelines for the preparation and handling of food donated to distributing organizations.[ 2002 c 217 § 2.]NOTES:Finding—Purpose—2002 c 217: See note following RCW 69.80.050.
WA Rev Code § 69.80.900 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.80 - Food Donation and Distribution—Liability.|69.80.900 - Construction.

RCW 69.80.900 Construction.Nothing in this chapter may be construed to create any liability of, or penalty against a donor or distributing organization except as provided in RCW 69.80.031.[ 1994 c 299 § 38; 1983 c 241 § 5.]NOTES:Intent—Finding—Severability—Conflict with federal requirements—1994 c 299: See notes following RCW 74.12.400.
WA Rev Code § 69.90.010 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.90 - Kosher Food Products.|69.90.010 - Definitions.

RCW 69.90.010 Definitions.Unless the context clearly requires otherwise, the definitions in this section apply throughout this chapter.(1) "Food product" includes any article other than drugs, whether in raw or prepared form, liquid or solid, or packaged or unpackaged, and which is used for human consumption.(2) "Kosher" means a food product which has been prepared, processed, manufactured, maintained, and sold in accordance with the requisites of traditional Jewish dietary law.(3) "Person" includes individuals, partnerships, corporations, and associations.[ 1985 c 127 § 2.]
WA Rev Code § 69.90.020 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.90 - Kosher Food Products.|69.90.020 - Sale of "kosher" and "kosher style" food products prohibited if not kosher—Representations—Penalty.

RCW 69.90.020 Sale of "kosher" and "kosher style" food products prohibited if not kosher—Representations—Penalty.(1) No person may knowingly sell or offer for sale any food product represented as "kosher" or "kosher style" when that person knows that the food product is not kosher and when the representation is likely to cause a prospective purchaser to believe that it is kosher. Such a representation can be made orally or in writing, or by display of a sign, mark, insignia, or simulation.(2) A person violating this section is guilty of a gross misdemeanor.[ 2003 c 53 § 349; 1985 c 127 § 3.]NOTES:Intent—Effective date—2003 c 53: See notes following RCW 2.48.180.
WA Rev Code § 69.90.030 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.90 - Kosher Food Products.|69.90.030 - Violation of chapter is violation of consumer protection act.

RCW 69.90.030 Violation of chapter is violation of consumer protection act.A violation of this chapter shall constitute a violation of the consumer protection act, chapter 19.86 RCW.[ 1985 c 127 § 4.]
WA Rev Code § 69.90.900 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.90 - Kosher Food Products.|69.90.900 - Short title.

RCW 69.90.900 Short title.This chapter shall be known as the sale of kosher food products act of 1985.[ 1985 c 127 § 1.]
WA Rev Code § 70.01.010 (2021)
2021 Revised Code of Washington|Title 70 - Public Health and Safety|Chapter 70.01 - General Provisions.|70.01.010 - Cooperation with federal government—Construction.

RCW 70.01.010 Cooperation with federal government—Construction.In furtherance of the policy of this state to cooperate with the federal government in the public health programs, the department of health, the state board of health, and the health care authority shall adopt such rules as may become necessary to entitle this state to participate in federal funds unless expressly prohibited by law. Any section or provision of the public health laws of this state which may be susceptible to more than one construction shall be interpreted in favor of the construction most likely to satisfy federal laws entitling this state to receive federal funds for the various programs of public health.[ 2011 1st sp.s. c 15 § 81; 2011 c 27 § 3; 1985 c 213 § 14; 1969 ex.s. c 25 § 1; 1967 ex.s. c 102 § 12.]NOTES:Effective date—Findings—Intent—Report—Agency transfer—References to head of health care authority—Draft legislation—2011 1st sp.s. c 15: See notes following RCW 74.09.010.Savings—Effective date—1985 c 213: See notes following RCW 43.20.050.Severability—1967 ex.s. c 102: See note following RCW 43.70.130.
WA Rev Code § 70.01.020 (2021)
2021 Revised Code of Washington|Title 70 - Public Health and Safety|Chapter 70.01 - General Provisions.|70.01.020 - Donation of blood by person sixteen or over—Parental consent.

RCW 70.01.020 Donation of blood by person sixteen or over—Parental consent.(1) Any person of the age of 18 years or over shall be eligible to donate blood, including donation through apheresis, in any voluntary and noncompensatory blood program without the necessity of obtaining parental permission or authorization.(2) Any person between the ages of 16 and 17 years old shall be eligible to donate blood, including donation through apheresis, in any voluntary and noncompensatory blood program after obtaining parental or legal guardian permission or authorization.[ 2021 c 16 § 1; 1969 c 51 § 1.]
WA Rev Code § 70.01.030 (2021)
2021 Revised Code of Washington|Title 70 - Public Health and Safety|Chapter 70.01 - General Provisions.|70.01.030 - Health care fees and charges—Estimate.

RCW 70.01.030 Health care fees and charges—Estimate.(1) Health care providers licensed under Title 18 RCW and health care facilities licensed under Title 70 RCW shall provide the following to a patient upon request:(a) An estimate of fees and charges related to a specific service, visit, or stay; and(b) Information regarding other types of fees or charges a patient may receive in conjunction with their visit to the provider or facility. Hospitals licensed under chapter 70.41 RCW may fulfill this requirement by providing a statement and contact information as described in RCW 70.41.400.(2) Providers and facilities listed in subsection (1) of this section may, after disclosing estimated charges and fees to a patient, refer the patient to the patient's insurer, if applicable, for specific information on the insurer's charges and fees, any cost-sharing responsibilities required of the patient, and the network status of ancillary providers who may or may not share the same network status as the provider or facility.(3) Except for hospitals licensed under chapter 70.41 RCW, providers and facilities listed in subsection (1) of this section shall post a sign in patient registration areas containing at least the following language: "Information about the estimated charges of your health services is available upon request. Please do not hesitate to ask for information."[ 2009 c 529 § 1.]
WA Rev Code § 70.01.040 (2021)
2021 Revised Code of Washington|Title 70 - Public Health and Safety|Chapter 70.01 - General Provisions.|70.01.040 - Provider-based clinics that charge a facility fee—Posting of required notice—Reporting requirements.

RCW 70.01.040 Provider-based clinics that charge a facility fee—Posting of required notice—Reporting requirements.(1) Prior to the delivery of nonemergency services, a provider-based clinic that charges a facility fee shall provide a notice to any patient that the clinic is licensed as part of the hospital and the patient may receive a separate charge or billing for the facility component, which may result in a higher out-of-pocket expense.(2) Each health care facility must post prominently in locations easily accessible to and visible by patients, including its website, a statement that the provider-based clinic is licensed as part of the hospital and the patient may receive a separate charge or billing for the facility, which may result in a higher out-of-pocket expense.(3) Nothing in this section applies to laboratory services, imaging services, or other ancillary health services not provided by staff employed by the health care facility.(4) As part of the year-end financial reports submitted to the department of health pursuant to RCW 43.70.052, all hospitals with provider-based clinics that bill a separate facility fee shall report:(a) The number of provider-based clinics owned or operated by the hospital that charge or bill a separate facility fee;(b) The number of patient visits at each provider-based clinic for which a facility fee was charged or billed for the year;(c) The revenue received by the hospital for the year by means of facility fees at each provider-based clinic; and(d) The range of allowable facility fees paid by public or private payers at each provider-based clinic.(5) For the purposes of this section:(a) "Facility fee" means any separate charge or billing by a provider-based clinic in addition to a professional fee for physicians' services that is intended to cover building, electronic medical records systems, billing, and other administrative and operational expenses.(b) "Provider-based clinic" means the site of an off-campus clinic or provider office that is owned by a hospital licensed under chapter 70.41 RCW or a health system that operates one or more hospitals licensed under chapter 70.41 RCW, is licensed as part of the hospital, and is primarily engaged in providing diagnostic and therapeutic care including medical history, physical examinations, assessment of health status, and treatment monitoring. This does not include clinics exclusively designed for and providing laboratory, X-ray, testing, therapy, pharmacy, or educational services and does not include facilities designated as rural health clinics.[ 2021 c 162 § 4; 2012 c 184 § 1.]NOTES:Effective date—2012 c 184: "This act takes effect January 1, 2013." [ 2012 c 184 § 2.]